NCT01524926 2023-12-11CREATEEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Completed582 enrolled
NCT02419287 2023-03-06Pilot Study of Crizotinib in Relapsed ALK+ LymphomasUniversity of Milano BicoccaPhase 2 Completed12 enrolled